ConductScience.org, home

Paper10992000

A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep.

Chapel SH and 3 others. J Pharmacol Exp Ther, 2000. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep. Papers, record 10992000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10992000

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
2000
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2007-11-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chapel SHS H
2Veng-Pedersen PP
3Schmidt RLR L
4Widness JAJ A

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ErythropoietinMajor topic
ReticulocytesMajor topic
Animals
Models, Biological
Phlebotomy
Sheep

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
GM57367NIGMS NIH HHSUnited StatesR21GM057367PubMed and NIHNIH RePORTER
P01 HL46925NHLBI NIH HHSUnited StatesP01HL046925PubMed and NIHNIH RePORTER
RR000359NCRR NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
23755260A biomathematical model of human erythropoiesis under erythropoietin and chemotherapy administration.PLoS One2013https://conductscience.org/library/papers/23755260PubMed
21460232Receptor-based dosing optimization of erythropoietin in juvenile sheep after phlebotomy.Drug Metab Dispos2011https://conductscience.org/library/papers/21460232PubMed
21209249Pharmacokinetic analysis of continuous erythropoietin receptor activator disposition in adult sheep using a target-mediated, physiologic recirculation model and a tracer interaction methodology.Drug Metab Dispos2011https://conductscience.org/library/papers/21209249PubMed
21107661Interpretation of transit compartments pharmacodynamic models as lifespan based indirect response models.J Pharmacokinet Pharmacodyn2011https://conductscience.org/library/papers/21107661PubMed
19725594Pharmacokinetics and pharmacodynamics of the erythropoietin Mimetibody construct CNTO 528 in healthy subjects.Clin Pharmacokinet2009https://conductscience.org/library/papers/19725594PubMed
19557192Quantitative analysis of mechanisms that govern red blood cell age structure and dynamics during anaemia.PLoS Comput Biol2009https://conductscience.org/library/papers/19557192PubMed
19371274Erythropoietin pharmacokinetic/pharmacodynamic analysis suggests higher doses in treating neonatal anemia.Pediatr Int2009https://conductscience.org/library/papers/19371274PubMed
18553126Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep.J Pharmacokinet Pharmacodyn2008https://conductscience.org/library/papers/18553126PubMed
18551354Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cells.J Pharmacokinet Pharmacodyn2008https://conductscience.org/library/papers/18551354PubMed
17891399Pharmacodynamic model for chemotherapy-induced anemia in rats.Cancer Chemother Pharmacol2008https://conductscience.org/library/papers/17891399PubMed
17516153Pharmacodynamic analysis of time-variant cellular disposition: reticulocyte disposition changes in phlebotomized sheep.J Pharmacokinet Pharmacodyn2007https://conductscience.org/library/papers/17516153PubMed
17516151Pharmacodynamic model of interleukin-21 effects on red blood cells in cynomolgus monkeys.J Pharmacokinet Pharmacodyn2007https://conductscience.org/library/papers/17516151PubMed
17457660Increased erythropoietin elimination in fetal sheep following chronic phlebotomy.Pharm Res2007https://conductscience.org/library/papers/17457660PubMed
17318417An assessment of recombinant human erythropoietin effect on reticulocyte production rate and lifespan distribution in healthy subjects.Pharm Res2007https://conductscience.org/library/papers/17318417PubMed
17025273Development and evaluation of a population pharmacokinetic-pharmacodynamic model of darbepoetin alfa in patients with nonmyeloid malignancies undergoing multicycle chemotherapy.AAPS J2006https://conductscience.org/library/papers/17025273PubMed
16892181A 'bottom-up' approach for endo-PK/PD analysis.Biopharm Drug Dispos2006https://conductscience.org/library/papers/16892181PubMed
12458668An integrated pharmacodynamic analysis of erythropoietin, reticulocyte, and hemoglobin responses in acute anemia.Pharm Res2002https://conductscience.org/library/papers/12458668PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10992000

GET https://conductscience.org/api/papers/v1/10992000/authors